Toggle Offcanvas
...
 
Eltrombopag Tenders

Eltrombopag Tenders

View Eltrombopag tenders, RFPs and contracts. Bid on readily available Eltrombopag tenders with the best and most comprehensive tendering platform, since 2002.
Eltrombopag is a medication used to treat low platelet counts in conditions like chronic immune thrombocytopenia. It stimulates the production of platelets, reducing the risk of bleeding.

Bidding for Eltrombopag tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Eltrombopag.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Eltrombopag market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Eltrombopag tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

24 Live Notices for Eltrombopag Tenders

Showing 1 to 20

Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V (Open House Model)
country Germany
posting date21 Aug 2025
deadline01 Jun 2027
Completion Of A Non-Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Elrombopag (Patent-Free Indication), Atc B02Bx05 F.D.Z. 01.10.25-30.09.27 (Plus Extension Option 1X12 Month)
country Germany
posting date20 Aug 2025
deadline05 Aug 2028
Open House Pharmaceutical Discount Contracts For The Active Ingredient Elrombopag, Atc B02Bx05
country Germany
posting date18 Aug 2025
deadline31 Jul 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Elrombopag, Atc B02Bx05
country Germany
posting date16 Aug 2025
deadline31 Jul 2027
Open House Pharmaceutical Department Of Eltrombopag, Excluded Area Of Application Of Severe Aplastic Anemia In The Specialist Information, Unless The Manufacturer Enjoys Sponsorship Protection, Atc B02Bx05
country Germany
posting date14 Aug 2025
deadline03 Aug 2027
The Purchase Of Drugs Of Eltrombopag (25 Mg And 50 Mg) For The Needs Of The Scientific And Practical Medical Center Of Children'S Oncology, Hematology And Immunology
country Uzbekistan
posting date14 Aug 2025
deadline29 Aug 2025
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By Means Of An Open House Model To The Active Ingredient Eltrombopag (Atc Code According To Who: B02Bx05)
country Germany
posting date13 Aug 2025
deadline30 Sep 2026
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V On Pharmaceuticals With The Active Ingredient Elrombopag (Atc Code: B02Bx05).
country Germany
posting date12 Aug 2025
deadline27 Jul 2027
Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V On Pharmaceuticals With The Active Ingredient Elrombopag (Atc Code: B02Bx05).
country Germany
posting date12 Aug 2025
deadline27 Jul 2027
Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredient/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
country Germany
posting date08 Aug 2025
deadline05 Mar 2027
Objective: Electronic Auction- Acquisition Of High Cost Drugs And Medical Products, Regulated By Ordinance No. 139-Dgp, Of July 7, 2015, In Which It Approves Regulatory Instructions For The Supply Of High Cost Drugs And Medical Products To The Beneficiaries Of The Army Health Fund (Fusex) (Eb 30-Ir- 10,004), To Meet The High Cost Pharmacy (Fac) Of The Military Hospital Brasilia (H Thousand To Brasilia).
country Brazil
posting date07 Aug 2025
deadline21 Aug 2025
Omalizuma Suminist (Doe), Nilotinis (Doe), Altrombopag (Doe), Dabrafenib (Doe), Secukinumab (Doe), Pasopanine (Doe), Trametinib (Doe), Everolimus (Doe) And Midostaurine (Doe)
country Spain
posting date06 Aug 2025
deadline21 Aug 2025
Omalizuma Suminist (Doe), Nilotinis (Doe), Altrombopag (Doe), Dabrafenib (Doe), Secukinumab (Doe), Pasopanine (Doe), Trametinib (Doe), Everolimus (Doe) And Midostaurine (Doe)
country Spain
posting date06 Aug 2025
deadline21 Aug 2025
Omalizuma Suminist (Doe), Nilotinis (Doe), Altrombopag (Doe), Dabrafenib (Doe), Secukinumab (Doe), Pasopanine (Doe), Trametinib (Doe), Everolimus (Doe) And Midostaurine (Doe)
country Spain
posting date05 Aug 2025
deadline20 Aug 2025
Delivery Of Medicinal Products
country Poland
posting date25 Jul 2025
deadline29 Aug 2025
Pharmaceutical Discounts From 01.09.2025 On Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date18 Jul 2025
deadline01 Jul 2027
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Eltrombopag, Atc B02Bx05 For The Time 01.09.2025 - 31.08.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Jul 2025
deadline05 Jul 2028
Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredient/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
country Germany
posting date03 Apr 2025
deadline05 Mar 2027
Supply Of Human Use Medicines That Contain The Following Active Ingredients: Alpelisib, Asciminib, Basiliaxab, Bolt Centers In The Field Of Valencian Public Health
country Spain
posting date13 Mar 2025
deadline30 Sep 2025
Open House Drug Discount Agreements Eltrombopag, Atc B02Bx05
country Germany
posting date17 Sep 2024
deadline05 Sep 2026

Share Share this page